Janney Montgomery Scott LLC Halozyme Therapeutics, Inc. Transaction History

Janney Montgomery Scott LLC

  • $32.8 Billion
  • Q2 2024

A detailed history of Janney Montgomery Scott LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 26,025 shares of HALO stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,025
Previous 16,454 58.17%
Holding current value
$1.54 Million
Previous $669,000 103.74%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
BUY
$37.81 - $52.4 $361,879 - $501,520
9,571 Added 58.17%
26,025 $1.36 Million
Q1 2024

May 01, 2024
BUY
$33.68 - $41.95 $123,470 - $153,788
3,666 Added 28.67%
16,454 $669,000
Q4 2023

Feb 07, 2024
BUY
$33.32 - $42.1 $426,096 - $538,374
12,788 New
12,788 $473,000
Q4 2022

Feb 01, 2023
BUY
$40.06 - $59.44 $332,097 - $492,757
8,290 New
8,290 $472,000
Q4 2021

Jan 27, 2022
SELL
$31.82 - $40.75 $177,714 - $227,588
-5,585 Closed
0 $0
Q3 2021

Oct 29, 2021
SELL
$38.47 - $46.42 $284,870 - $343,740
-7,405 Reduced 57.01%
5,585 $227,000
Q2 2021

Jul 26, 2021
SELL
$38.84 - $51.31 $278,599 - $368,046
-7,173 Reduced 35.58%
12,990 $590,000
Q1 2021

Apr 27, 2021
BUY
$39.51 - $51.45 $231,765 - $301,805
5,866 Added 41.03%
20,163 $841,000
Q4 2020

Jan 25, 2021
BUY
$25.81 - $43.62 $369,005 - $623,635
14,297 New
14,297 $611,000
Q4 2019

Jan 21, 2020
SELL
$14.93 - $19.53 $674,880 - $882,814
-45,203 Closed
0 $0
Q3 2019

Oct 29, 2019
SELL
$15.2 - $17.69 $274,952 - $319,994
-18,089 Reduced 28.58%
45,203 $701,000
Q2 2019

Jul 29, 2019
SELL
$14.75 - $17.26 $53,557 - $62,671
-3,631 Reduced 5.43%
63,292 $1.09 Million
Q1 2019

Apr 30, 2019
SELL
$13.94 - $17.58 $20,547 - $25,912
-1,474 Reduced 2.16%
66,923 $1.08 Million
Q4 2018

Feb 01, 2019
SELL
$13.33 - $18.66 $60,678 - $84,940
-4,552 Reduced 6.24%
68,397 $1 Million
Q3 2018

Nov 05, 2018
SELL
$16.68 - $18.41 $17,313 - $19,109
-1,038 Reduced 1.4%
72,949 $1.33 Million
Q2 2018

Jul 24, 2018
SELL
$16.87 - $20.3 $14,002 - $16,849
-830 Reduced 1.11%
73,987 $1.25 Million
Q1 2018

Apr 19, 2018
SELL
$17.06 - $21.2 $36,150 - $44,922
-2,119 Reduced 2.75%
74,817 $1.47 Million
Q4 2017

Feb 14, 2018
SELL
$16.75 - $20.8 $124,569 - $154,689
-7,437 Reduced 8.81%
76,936 $1.56 Million
Q3 2017

Nov 15, 2017
BUY
$11.76 - $17.4 $992,226 - $1.47 Million
84,373
84,373 $1.47 Million

Others Institutions Holding HALO

# of Institutions
488
Shares Held
122M
Call Options Held
208K
Put Options Held
66.3K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $8.25B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email